https://orcid.org/0000-0003-3631-3941
References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019; 69:7–34.
- ESMO. Performance scales: Karnofsky and ECOG Scores. 2008 [accessed 2016 Feb 4]. Available from: oncologypro.esmo.org/Guidelines-Practice/Practice-Tools/Performance-Scores
- Karnofsky DA, Burchenal JH. The clinical evluation of chemotherapeutic agents in cancer. In: McLeod CM, Editor. Evaluation of chemotherapeutic agents in cancer. New York: Columbia University Press; 1949. p. 191–205.
- Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.
- Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trials of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis. 1960;11:7–33.
- West HJ, Jin JO. JAMA Oncology Patient Page. Performance Status in Patients With Cancer. JAMA Oncol. 2015;1:998–998.
- Aier I, Semwal R, Sharma A, et al. A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer. Cancer Epidemiol. 2019; 58:104–110.
- NCCN. NCCN Clinical Practice Guidelines in Oncology: Rectal cancer. Version 6.2020. 2020 [accessed 2020 Oct 14]. Available from: www.nccn.org
- NCCN. NCCN Clinical Practice Guidelines in Oncology: Older adult oncology. Version 1.2020. 2020 [accessed 2020 Oct 14]. Available from: www.nccn.org
- NCCN. NCCN Clinical Practice Guidelines in Oncology: Gastric cancer. Version 3.2020. 2020 [accessed 2020 Oct 14]. Available from: www.nccn.org
- NCCN. NCCN Clinical Practice Guidelines in Oncology: Non-small cell lung cancer. Version 8.2020. 2020 [accessed 2020 Oct 14]. Available from: www.nccn.org
- NCCN. NCCN Clinical Practice Guidelines in Oncology: Colon cancer. Version 4.2020. 2020 [accessed 2020 Oct 14]. Available from: www.nccn.org
- Zach. What is a strong correlation? 2020 [accessed 2020 Oct 14]. Available from: https://www.statology.org/what-is-a-strong-correlation/
- Bones AK. We knew the future all along: scientific hypothesizing is much more accurate than other forms of precognition – a satire in one part. Perspect Psychol Sci. 2012;7:307–309.
- Kelly CM, Shahrokni A. Moving beyond Karnofsky and ECOG performance status assessments with new technologies. J Oncol. 2016;2016:6186543.
- Taylor AE, Olver IN, Sivanthan T, et al. Observer error in grading performance status in cancer patients. Support Care Cancer. 1999;7:332–335.
- Tarhini A, Rao AS, Corman S, et al. Healthcare Resource Utilization (HCRU) in patients receiving ipilimumab for advanced melanoma: impact of survival and Eastern Cooperative Oncology Group (ECOG) Status. Ann Oncol. 2014;25:iv381.
- Sheffield KM, Bowman L, Smith DM, et al. Development and validation of a claims-based approach to proxy ECOG performance status across ten tumor groups. J Comp Eff Res. 2018;7:193–208.